Business
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference in Boca Raton, FL.
About this update from Hoth Therapeutics, Inc.
[{"type":"text","content":"NobleCon is the preeminent showcase of small and microcap companies","length":67,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference in Boca Raton, FL.","length":308,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Hoth Therapeutics Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Hoth Therapeutics Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":1280,"height":720,"url":"https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.jpg"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/eImoPut.sTDSLUwGblw0Ew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.jpg","width":960,"height":540},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Z.UeF048HHMcT.N0pAqkVw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUwO2NmPXdlYnA-/https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.jpg","width":1200,"height":675}},"href":"https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"To learn more about NobleCon and registration to attend or scheduling a one-on-one meeting with management please visit https://nobleconference.com/","length":148,"tagName":"p"},{"type":"text","content":"About Hoth Therapeutics, Inc.Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate therapeutics that hold immense potential to create breakthroughs and diversify treatment options. To learn more, please visit https://ir.hoththerapeutics.com/ .","length":684,"tagName":"p"},{"type":"text","content":"Forward-Looking StatementThis press release includes forward...